280 related articles for article (PubMed ID: 25266168)
1. Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough.
Hausdorff WP; Hoet B; Adegbola RA
Expert Rev Vaccines; 2015 Mar; 14(3):413-28. PubMed ID: 25266168
[TBL] [Abstract][Full Text] [Related]
2. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination?
Azzari C; Cortimiglia M; Nieddu F; Moriondo M; Indolfi G; Mattei R; Zuliani M; Adriani B; Degl'Innocenti R; Consales G; Aquilini D; Bini G; Di Natale ME; Canessa C; Ricci S; de Vitis E; Mangone G; Bechini A; Bonanni P; Pasinato A; Resti M
Hum Vaccin Immunother; 2016; 12(2):344-50. PubMed ID: 26647277
[TBL] [Abstract][Full Text] [Related]
4. Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement.
Hausdorff WP; Hanage WP
Hum Vaccin Immunother; 2016; 12(2):358-74. PubMed ID: 26905681
[TBL] [Abstract][Full Text] [Related]
5. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
Cheung YB; Zaman SM; Nsekpong ED; Van Beneden CA; Adegbola RA; Greenwood B; Cutts FT
Pediatr Infect Dis J; 2009 Nov; 28(11):990-5. PubMed ID: 19536041
[TBL] [Abstract][Full Text] [Related]
6. The future of pneumococcal disease prevention.
Rodgers GL; Klugman KP
Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
[TBL] [Abstract][Full Text] [Related]
7. Change in Pneumococcus Serotypes but not Mortality or Morbidity in Pre- and Post-13-Valent Polysaccharide Conjugate Vaccine Era: Epidemiology in a Pediatric Intensive Care Unit over 10 Years.
Hon KL; Chan KH; Ko PL; Cheung MHY; Tsang KYC; Chan LCN; Chan RWY; Leung TF; Ip M
J Trop Pediatr; 2018 Oct; 64(5):403-408. PubMed ID: 29126217
[TBL] [Abstract][Full Text] [Related]
8. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.
Davis SM; Deloria-Knoll M; Kassa HT; O'Brien KL
Vaccine; 2013 Dec; 32(1):133-45. PubMed ID: 23684824
[TBL] [Abstract][Full Text] [Related]
9. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine.
Kuo CY; Hwang KP; Hsieh YC; Cheng CH; Huang FL; Shen YH; Huang YC; Chiu CH; Chen PY; Lin TY
Vaccine; 2011 Jul; 29(32):5171-7. PubMed ID: 21621578
[TBL] [Abstract][Full Text] [Related]
10. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
Dagan R; Givon-Lavi N; Zamir O; Sikuler-Cohen M; Guy L; Janco J; Yagupsky P; Fraser D
J Infect Dis; 2002 Apr; 185(7):927-36. PubMed ID: 11920317
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era.
Onwubiko C; Swiatlo E; McDaniel LS
J Clin Microbiol; 2008 Nov; 46(11):3621-5. PubMed ID: 18845823
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design Principles.
Croucher NJ; Løchen A; Bentley SD
Annu Rev Microbiol; 2018 Sep; 72():521-549. PubMed ID: 30200849
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E
Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717
[TBL] [Abstract][Full Text] [Related]
14. [7-valent conjugate Pneumococcal vaccine and nasopharyngeal cavity].
Piffer S
Ann Ig; 2002; 14(6 Suppl 7):31-7. PubMed ID: 12638362
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance and the potential impact of pneumococcal conjugate vaccines.
Dagan R
Commun Dis Intell Q Rep; 2003; 27 Suppl():S134-42. PubMed ID: 12807290
[TBL] [Abstract][Full Text] [Related]
18. The worldwide impact of the seven-valent pneumococcal conjugate vaccine.
Fitzwater SP; Chandran A; Santosham M; Johnson HL
Pediatr Infect Dis J; 2012 May; 31(5):501-8. PubMed ID: 22327872
[TBL] [Abstract][Full Text] [Related]
19. Estimation of vaccine efficacy against acquisition of pneumococcal carriage.
Rinta-Kokko H; Dagan R; Givon-Lavi N; Auranen K
Vaccine; 2009 Jun; 27(29):3831-7. PubMed ID: 19490983
[TBL] [Abstract][Full Text] [Related]
20. Rationale and prospects for novel pneumococcal vaccines.
Moffitt K; Malley R
Hum Vaccin Immunother; 2016; 12(2):383-92. PubMed ID: 26535755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
